CN Patent

CN109096370B — 多肽环氧酮化合物

Assigned to CENTRAX INTERNATIONAL Inc · Expires 2022-03-18 · 4y expired

What this patent protects

本发明公开的新化合物和药物组合物可作为蛋白酶体的抑制剂。本发明提供的化合物能抑制蛋白酶体的CT‑L，T‑L和PGPH三种活性，可用于治疗与蛋白酶体相关的各种疾病。

USPTO Abstract

本发明公开的新化合物和药物组合物可作为蛋白酶体的抑制剂。本发明提供的化合物能抑制蛋白酶体的CT‑L，T‑L和PGPH三种活性，可用于治疗与蛋白酶体相关的各种疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN109096370B
Jurisdiction
CN
Classification
—
Expires
2022-03-18
Drug substance claim
No
Drug product claim
No
Assignee
CENTRAX INTERNATIONAL Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.